{"transactions":[{"id":832720,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56921,"kind":"person","name":"Bitterman Chris T.","position":1,"cik":"0001969681","reported_name":"Bitterman Chris T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Pres Sales & Marketing"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:20:52.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":2.8,"value":8400.0,"ownership":{"direct":true},"balance_after":19000,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-16","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001087294-26-000034","document":"wk-form4_1774041649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000034/wk-form4_1774041649.xml","form_type":"4"}},{"id":1201685,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56921,"kind":"person","name":"Bitterman Chris T.","position":1,"cik":"0001969681","reported_name":"Bitterman Chris T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Pres Sales & Marketing"}}],"security":"Options (right to buy)","published_at":"2025-03-18T21:11:02.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":5.17,"value":14217.5,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":5.17,"exercise_date":"2029-03-17","expiration_date":"2035-03-17","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001628280-25-013531","document":"wk-form4_1742332253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025013531/wk-form4_1742332253.xml","form_type":"4"}},{"id":1561035,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56921,"kind":"person","name":"Bitterman Chris T.","position":1,"cik":"0001969681","reported_name":"Bitterman Chris T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Pres Sales & Marketing"}}],"security":"Options (right to buy)","published_at":"2024-03-27T00:25:02.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":1.71,"value":4702.5,"ownership":{"direct":true},"balance_after":13250,"derivative":{"exercise_price":1.71,"exercise_date":"2028-03-25","expiration_date":"2034-03-25","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001214659-24-005213","document":"marketforms-65387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000121465924005213/marketforms-65387.xml","form_type":"4"}},{"id":1561034,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56921,"kind":"person","name":"Bitterman Chris T.","position":1,"cik":"0001969681","reported_name":"Bitterman Chris T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Pres Sales & Marketing"}}],"security":"Common Stock","published_at":"2024-03-27T00:25:02.000Z","date":"2024-03-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":593,"price":1.81,"value":1073.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":4683,"source":{"system":"sec-edgar","filing":"0001214659-24-005213","document":"marketforms-65387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000121465924005213/marketforms-65387.xml","form_type":"4"}},{"id":1938311,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56921,"kind":"person","name":"Bitterman Chris T.","position":1,"cik":"0001969681","reported_name":"Bitterman Chris T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Pres Sales & Marketing"}}],"security":"Options (right to buy)","published_at":"2023-03-27T21:49:36.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12500,"derivative":{"exercise_price":1.97,"exercise_date":"2027-03-24","expiration_date":"2033-03-24","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-23-021286","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919123021286/doc4.xml","form_type":"4"}}]}